You just read:

Nektar Therapeutics Announces Initiation of Two Clinical Studies of Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Psoriasis and Atopic Dermatitis

News provided by

Nektar Therapeutics

Oct 07, 2019, 09:00 ET